Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-25T06:45:41.526Z Has data issue: false hasContentIssue false
  • English
  • Français

Bacteriocin-like activity of group B and group C streptococci of human and of animal origin

Published online by Cambridge University Press:  19 October 2009

Christine R. Schofield  and
J. R. Tagg
Christine R. Schofield
Affiliation:
Department of Microbiology, University of Otago, Dunedin, New Zealand
J. R. Tagg
Affiliation:
Department of Microbiology, University of Otago, Dunedin, New Zealand
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

An inhibitor ‘fingerprinting’ technique was used to test 120 group B and 50 group C streptococcus strains for production of inhibitory activity. The incidence of inhibitor production was low. Five of 70 group B streptococci of animal origin and one of 50 from human sources consistently produced inhibitory activity. Six of 20 animal strains and three of 30 human strains of group C streptococci were inhibitor producers. These included two Streptococcus dysgalactiae, three S. equisimilis and four S. zooepidemicus.

The temperature of incubation and species of origin of the blood used in the culture medium were critical determinants of inhibitor production. Investigation of inhibitors for their spectrum of activity, heat stability, sensitivity to trypsin, dialysability and mode of action indicated that five of the group B and seven of the group C streptococci produced inhibitors that had bacteriocin-line properties. Three bovine strains of group B streptococci produced very similar inhibitory activity. A greater variety of bacteriocin-like substances was detected in the group C streptococcus strains. Two of the S. zooepidemicus strains were each found to Produce more than one inhibitory substance.

Type
Research Article
Information
Journal of Hygiene , Volume 90 , Issue 1 , February 1983 , pp. 7 - 18
Copyright
Copyright © Cambridge University Press 1983

References

REFERENCES

Baker, C. J. (1980). Group B streptococcal infections. Advances in Internal Medicine 25, 475–501.Google ScholarPubMed
Bryans, J. T. & Moore, B. O. (1972). Group C streptococcal infections of the horse. In Streptococci and Streptococcal Diseases. Recognition, understanding, and management (ed. Wannamaker, L. W. and Matsen, J. M.), pp. 327–338. London, New York: Academic Press.Google Scholar
Butter, M. N. W. & De Moor, C. E. (1907). Streptococcus agaladiae as a cause of meningitis in the newborn, and of bacteraemia in adults. Differentiation of human and animal varieties. Antonie van Leeuwenhoek 33, 439–450.CrossRefGoogle Scholar
Duca, E., Teodorovici, G., Radu, C., Vita, A., Talasman-Niculescu, P., Bernescu, E.; Feldi, C. & Rosoa, V. (1969). A new nephritogenic streptococcus. Journal of Hygiene 67, 691–698.Google ScholarPubMed
El, Ghoroury A. A. (1950 a). Comparative studies of group B streptotocci ofhuman and bovine origin. I. Cultural and biochemical characters. American Journal of Public Health 40, 1273–1277.Google Scholar
El, Ghoroury A. A. (1950 b). Comparative studies of group B streptococci of human and bovine origin. II. Serological characters. American Journal of Public Health 40, 1278–1284.Google Scholar
Haug, R. H., Bakken, G. & Berdal, B. D. (1979). Experimental udder infection of cows with human and bovine strains of group-B streptococci. In Pathogenic Streptococci (ed. Parker, M.T.), pp. 167–168. Chertsey: Reedbooks Ltd.Google Scholar
Haug, R. H., Gudding, R. & Bakken, G. (1981). Serotyping and bacteriophago typing of human and bovine group-B streptococci. Journal of Medical Microbiology 14, 479–482.CrossRefGoogle ScholarPubMed
Higgs, T. M., Neave, F. K. & Bramley, A. J. (1980). Difierences in intramammary pathogenicity of four strains of Streptococcus dysgalactiae. Journal of Medical Microbiology 13, 393–399.Google Scholar
Hsu, C. Y. & Wiseman, G. M. (1967). Antibacterial substances from staphylococci. Canadian Journal of Microbiology 13, 947–955.Google Scholar
Jelinkova, J. (1977). Group B streptococci in the human population. Current Topics in Microbiology and Immunology 76, 127–125.Google Scholar
Johnson, D. W., Tagg, J. R. & Wannamaker, L. W. (1979). Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. Journal of Medicine Microbiology 12, 413–427.Google Scholar
Kramer, J. & Brandis, H. (1972). Charakterisierung eines Streptococcus agalactiae-Bacteriocins. Zentralblatt fur Bakteriologie, Parasitenkunde, Infeclionskrankheilen und Hygiene. Erste Alteilung Originate A 219, 290–301.Google Scholar
Noble, W. C., Lloyd, D. H. & Appiah, S. N. (1980). Inhibition of Dematophihis congolensis infection in a mouse model by antibiotic-producing staphylococci. British Journal of Experimental Pathology 61, 644–647.Google Scholar
Parker, M. T. (1977). Noenatal streptococcal infections. Postgraduate Medical Journal 53, 598–606.CrossRefGoogle Scholar
Ross, P. W. (1978). Ecology of group B streptococci. In Streptococci (ed. Skinner, F. A. and Quesnel, L. B.), pp. 127–142. London, New York: Academic Press.Google ScholarPubMed
Stamm, A. M. & Cobbs, C. G. (1980). Group C streptococcal pneumonia: report of a fatal case and review of the literature. Reviews of Infectious Diseases 2, 889–898.Google Scholar
Stringer, J. (1980). The development of a phage-typing system for group-B streptococci. Journal of Medical Microbiology 13, 133–144.CrossRefGoogle ScholarPubMed
Tagg, J. R. & Bannister, L. V. (1979). ‘Fingerprinting’ haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. Journal of Medical Microbiology 12, 397–441.CrossRefGoogle ScholarPubMed
Tagg, J. R. & Martin, D. (1980). Bacteriocin ‘fingerprinting’ of group B streptococcus strains of bovine and human origin. Proceedings of the University of Otago Medical School 58, 22–23.Google Scholar
Tagg, J. R., Dajani, A. S. & Wannamaker, L. W. (1975). Bacteriocinof a group B streptococcus: partial purification and characterization. Antimicrobial Agents and Chemotherapy 7, 764–722.Google Scholar
Tagg, J. R., Dajani, A. S. & Wannamaker, L. W. (1976). Bacteriocins of gram-positive bacteria. Bacteriological Reviews 40, 722–756.Google Scholar
Tompkins, G. R. & Tagg, J. R. (1981). Antagonistic activity of oral Actinomyces due to acid production. Proceedings of the University Otago Medical School 59, 60–61.Google Scholar
Tzannetis, S., Poulaki-Tsontou, A. & Papavassiliou, J. (1974). Bactcriocino production in group B streptococci. Pathalogia et Mikrobiologia 41, 51–57.Google Scholar
Wilkinson, H. W. (1978). Group B streptococcal infection in humans Annual Review of Microbiology 32, 41–47.Google Scholar
Wilkinson, H. W. & Moody, M. D. (1969). Serological relationships of type I antigens of group B streptococci. Journal of Bacteriology 97, 629–634.CrossRefGoogle ScholarPubMed
Wilson, C. D. & Salt, G. F. H. (1978). Streptococci in animal disease. In Streptococci (ed. Skinner, F. A. and Quesnel, L. B.), pp. 143–156. London, New York: Academic Press.Google Scholar